<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD05460000_2</Organism_ID>
  <Organism>Rat</Organism>
  <Organism_Latin>Rattus norvegicus</Organism_Latin>
  <UniProt_ID>P68403</UniProt_ID>
  <Seq_Length>671</Seq_Length>
  <Molecule_Weight>76751</Molecule_Weight>
  <KEGG_ID>rno:25023</KEGG_ID>
  <Orthology_ID>K02677</Orthology_ID>
  <EBI_ID>EBI-397092</EBI_ID>
  <Function_Summary>Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase involved in various cellular processes such as regulation of the B-cell receptor (BCR) signalosome, oxidative stress-induced apoptosis, androgen receptor-dependent transcription regulation, insulin signaling and endothelial cells proliferation. Plays a key role in B-cell activation by regulating BCR-induced NF-kappa-B activation. Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11/CARMA1 at 'Ser-559', 'Ser-644' and 'Ser-652'. Phosphorylation induces CARD11/CARMA1 association with lipid rafts and recruitment of the BCL10-MALT1 complex as well as MAP3K7/TAK1, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. Plays a direct role in the negative feedback regulation of the BCR signaling, by down-modulating BTK function via direct phosphorylation of BTK at 'Ser-180', which results in the alteration of BTK plasma membrane localization and in turn inhibition of BTK activity. Involved in apoptosis following oxidative damage: in case of oxidative conditions, specifically phosphorylates 'Ser-36' of isoform p66Shc of SHC1, leading to mitochondrial accumulation of p66Shc, where p66Shc acts as a reactive oxygen species producer. Acts as a coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and specifically mediating phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag for epigenetic transcriptional activation that prevents demethylation of histone H3 'Lys-4' (H3K4me) by LSD1/KDM1A. In insulin signaling, may function downstream of IRS1 in muscle cells and mediate insulin-dependent DNA synthesis through the RAF1-MAPK/ERK signaling cascade. May participate in the regulation of glucose transport in adipocytes by negatively modulating the insulin-stimulated translocation of the glucose transporter SLC2A4/GLUT4. Under high glucose in pancreatic beta-cells, is probably involved in the inhibition of the insulin gene transcription, via regulation of MYC expression. In endothelial cells, activation of PRKCB induces increased phosphorylation of RB1, increased VEGFA-induced cell proliferation, and inhibits PI3K/AKT-dependent nitric oxide synthase (NOS3/eNOS) regulation by insulin, which causes endothelial dysfunction. Also involved in triglyceride homeostasis (By similarity).</Function_Summary>
  <Catalytic_Mechanism>ATP + a protein = ADP + a phosphoprotein.</Catalytic_Mechanism>
  <Pfam_ID>PF00130:C1_1@@PF00168:C2@@PF00069:Pkinase@@PF00433:Pkinase_C</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>PKC-B</Alias>
      <Alias>PKC-beta</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an androgen receptor.</Detail>
      <Keyword>Androgen receptor binding</Keyword>
      <Ontology_ID>GO:0050681</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a histone, any of a group of water-soluble proteins found in association with the DNA of plant and animal chromosomes. They are involved in the condensation and coiling of chromosomes during cell division and have also been implicated in nonspecific suppression of gene activity.</Detail>
      <Keyword>Histone binding</Keyword>
      <Ontology_ID>GO:0042393</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.</Detail>
      <Keyword>Protein serine/threonine kinase activity</Keyword>
      <Ontology_ID>GO:0004674</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.</Detail>
      <Keyword>Kinase activity</Keyword>
      <Ontology_ID>GO:0016301</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with chromatin, the network of fibers of DNA and protein that make up the chromosomes of the eukaryotic nucleus during interphase.</Detail>
      <Keyword>Chromatin binding</Keyword>
      <Ontology_ID>GO:0003682</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with zinc (Zn) ions.</Detail>
      <Keyword>Zinc ion binding</Keyword>
      <Ontology_ID>GO:0008270</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>The function of a transcription cofactor that activates transcription in conjuction with a ligand-dependent nuclear receptor from a RNA polymerase II promoter; does not bind DNA itself.</Detail>
      <Keyword>Ligand-dependent nuclear receptor transcription coactivator activity</Keyword>
      <Ontology_ID>GO:0030374</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a phosphate group to the threonine-6 residue of the N-terminal tail of histone H3.</Detail>
      <Keyword>Histone kinase activity (H3-T6 specific)</Keyword>
      <Ontology_ID>GO:0035403</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + a protein = ADP + a phosphoprotein. This reaction requires diacylglycerol.</Detail>
      <Keyword>Protein kinase C activity</Keyword>
      <Ontology_ID>GO:0004697</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the growth of all or part of an organism so that it occurs at its proper speed, either globally or in a specific part of the organism's development.</Detail>
      <Keyword>Regulation of growth</Keyword>
      <Ontology_ID>GO:0040008</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the regulated release of dopamine.</Detail>
      <Keyword>Regulation of dopamine secretion</Keyword>
      <Ontology_ID>GO:0014059</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in adaptive immunity. Vertebrates can develop a broad and almost infinite repertoire of antigen-specific receptors, which allows vertebrates to recognize almost any potential pathogen or toxin and to mount antigen-specific responses to it. Two types of adaptive immunity systems have evolved in vertebrates in order to generate immune receptor diversity. The jawed vertebrates strategy uses the V(D)JC recombination to achieve combinatorial diversity of immunoglobulin-based B cell receptors and T cell receptors. The jawless vertebrate strategy uses the somatic rearrangements of variable leucine-rich cassettes in the variable lymphocyte receptors (VLRs). The hallmarks of an adaptive immune system is the production of antigen-specific recognition receptor by somatic gene rearrangement. The long life of some antigen-primed cytotoxic lymphocytes and plasma cells provide protective memory to prevent reinvasion.</Detail>
      <Keyword>Adaptive immunity</Keyword>
      <Ontology_ID>KW-1064</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The change in morphology and behavior of a mature or immature B cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.</Detail>
      <Keyword>B cell activation</Keyword>
      <Ontology_ID>GO:0042113</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.</Detail>
      <Keyword>Intracellular signal transduction</Keyword>
      <Ontology_ID>GO:0035556</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus.</Detail>
      <Keyword>Response to vitamin D</Keyword>
      <Ontology_ID>GO:0033280</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.</Detail>
      <Keyword>Response to ethanol</Keyword>
      <Ontology_ID>GO:0045471</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.</Detail>
      <Keyword>Response to drug</Keyword>
      <Ontology_ID>GO:0042493</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B cell.</Detail>
      <Keyword>Positive regulation of B cell receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0050861</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The alteration of DNA or protein in chromatin, which may result in changing the chromatin structure.</Detail>
      <Keyword>Chromatin modification</Keyword>
      <Ontology_ID>GO:0016568</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter.</Detail>
      <Keyword>Regulation of transcription from RNA polymerase II promoter</Keyword>
      <Ontology_ID>GO:0006357</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that decreases the frequency, rate or extent of glucose transport. Glucose transport is the directed movement of the hexose monosaccharide glucose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Negative regulation of glucose transport</Keyword>
      <Ontology_ID>GO:0010829</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of an I-kappaB kinase/NF-kappaB induced cascade.</Detail>
      <Keyword>Positive regulation of I-kappaB kinase/NF-kappaB cascade</Keyword>
      <Ontology_ID>GO:0043123</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of RNA on a template of DNA.</Detail>
      <Keyword>Transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0006351</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Regulation of transcription</Keyword>
      <Ontology_ID>GO:0045449</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the formation and development of teeth, the hard, bony appendages that are borne on the jaws, or on other bones in the walls of the mouth or pharynx of most vertebrates.</Detail>
      <Keyword>Positive regulation of odontogenesis of dentine-containing tooth</Keyword>
      <Ontology_ID>GO:0042488</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling.</Detail>
      <Keyword>Negative regulation of insulin receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0046627</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.</Detail>
      <Keyword>Positive regulation of vascular endothelial growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0030949</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.</Detail>
      <Keyword>Response to glucose stimulus</Keyword>
      <Ontology_ID>GO:0009749</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Transcription</Keyword>
      <Ontology_ID>GO:0006350</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell.</Detail>
      <Keyword>B cell receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0050853</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.</Detail>
      <Keyword>Positive regulation of NF-kappaB transcription factor activity</Keyword>
      <Ontology_ID>GO:0051092</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in immunity, any immune system process that functions in the response of an organism to a potential internal or invasive threat. The vertebrate immune system is formed by the innate immune system (composed of phagocytes, complement, antimicrobial peptides, etc) and by the adaptive immune system which consists of T- and B-lymphocytes.</Detail>
      <Keyword>Immunity</Keyword>
      <Ontology_ID>KW-0391</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases angiogenesis.</Detail>
      <Keyword>Positive regulation of angiogenesis</Keyword>
      <Ontology_ID>GO:0045766</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>500</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>635</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>195</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>642</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>16</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>314</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-acetylalanine</PTM_Type>
    </PTM>
    <PTM>
      <Position>504</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>17</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>324</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>662</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>250</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>661</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MADPAAGPPPSEGEESTVRFARKGALRQKNVHEVKNHKFTARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPASDDPRSKHKFKIHTYSSPTFCDHCGSLLYGLIHQGMKCDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKARDKRDTSNFDKEFTRQPVELTPTDKLFIMNLDQNEFAGFSYTNPEFVINV</Protein_Seq>
    <DNA_Seq>GCGGCCCTGCGGTCCCCGGGCGGCAGCAGCGGCCGCCTAGTCCCGCGCCTCTCCGGGCTTACAGCCCCGCGGTCCCGCCGCCCCGGGGCCGCCACCTCTCGGGGCTCCCCCCAGTCCCCGCGCGCGCAAGATGGCTGACCCGGCTGCGGGGCCGCCGCCGAGCGAGGGCGAGGAGAGCACGGTGCGCTTCGCCCGCAAAGGCGCCCTCCGGCAGAAGAACGTGCACGAGGTGAAGAACCACAAATTCACCGCCCGCTTCTTCAAGCAGCCCACCTTCTGCAGCCACTGCACCGACTTCATTTGGGGCTTAGGTTTGCAGGGATTCCAGAGTCAGGTCTGCTGCTTTGTTGTACACAAGCGCTGCCATGAATTCGTCACGTTCTCCTGCCCTGGTGCAGACAAGGGCCCGGCCTCTGATGACCCACGGAGCAAACACAAGTTTAAGATCCACACCTACTCCAGCCCTACCTTCTGTGACCACTGTGGATCACTGCTGTATGGGCTCATCCACCAGGGGATGAAATGCGACACCTGTATGATGAATGTCCACAAGCGCTGCGTGATGAACGTCCCCAGCCTCTGTGGCACCGACCACACAGAACGCCGTGGCCGCATCTACATCCAGGCCCACATCGACAGGGAGGTCCTCATCGTTGTTGTAAGAGATGCTAAAAATCTGGTACCTATGGACCCCAACGGCTTGTCAGATCCCTACGTAAAACTGAAACTGATCCCTGATCCCAAAAGTGAGAGCAAGCAGAAGACCAAGACTATCAAATGCTCCCTCAACCCGGAGTGGAACGAAACCTTCAGATTTCAGCTGAAGGAATCAGACAAAGACAGAAGACTGTCCGTAGAGATCTGGGATTGGGACCTGACCAGCAGGAATGACTTCATGGGATCTCTGTCGTTTGGGATTTCAGAACTACAGAAAGCCGGAGTGGATGGCTGGTTCAAGTTACTAAGCCAGGAAGAAGGCGAGTACTTTAATGTGCCGGTGCCGCCGGAAGGAAGCGAGGGCAATGAAGAGCTGCGGCAGAAGTTTGAGAGAGCCAAGATTGGCCAAGGTACCAAGGCTCCAGAAGAAAAGACAGCGAACACTATATCCAAATTTGACAACAATGGCAACAGGGACCGGATGAAACTGACCGATTTTAACTTCCTGATGGTGCTGGGGAAAGGCAGCTTTGGCAAGGTCATGCTCTCAGAGCGGAAGGGTACAGATGAACTCTATGCCGTGAAGATCCTGAAGAAAGATGTGGTGATCCAAGATGACGATGTGGAGTGCACAATGGTGGAGAAGAGGGTGCTGGCCCTGCCTGGGAAGCCCCCATTCCTGACTCAGCTCCATTCCTGCTTCCAGACCATGGACCGCCTCTACTTTGTGATGGAGTATGTGAACGGGGGCGACCTCATGTACCACATCCAACAAGTTGGCCGTTTCAAGGAGCCCCATGCTGTATTTTACGCTGCAGAGATTGCCATCGGTCTTTTCTTCTTGCAGAGCAAGGGCATCATTTACCGTGACCTGAAACTTGACAACGTGATGCTGGATTCCGAGGGGCACATCAAAATCGCTGACTTTGGCATGTGTAAAGAGAATATCTGGGATGGGGTGACAACCAAGACATTCTGTGGCACTCCAGACTACATTGCCCCAGAGATCATTGCTTATCAGCCCTACGGGAAGTCTGTGGACTGGTGGGCGTTTGGAGTCCTGCTGTATGAAATGTTGGCTGGCCAGGCACCTTTTGAAGGGGAGGATGAGGATGAACTCTTCCAGTCAATCATGGAGCACAACGTGGCGTATCCCAAGTCCATGTCTAAGGAAGCTGTGGCAATCTGCAAAGGGCTAATGACCAAACACCCAGGCAAGCGCCTGGGTTGTGGGCCTGAAGGGGAACGAGACATTAAGGAGCATGCATTTTTCCGGTATATCGACTGGGAGAAACTCGAACGCAAGGAGATTCAGCCACCTTATAAACCAAAAGCTAGAGACAAGCGAGACACCTCCAACTTCGACAAAGAGTTCACCAGGCAGCCTGTGGAACTGACTCCCACTGACAAACTCTTCATCATGAACTTGGACCAAAATGAATTTGCTGGCTTCTCGTATACTAACCCAGAGTTTGTCATTAATGTGTAGGTGAATGCAGATTCCATCGCTGAGCCTGTGTGTAAGGCTGCAGGCTGAATGTCTATTATCAATTCCAGTCTTCCAGGATTCATGGTGCCTCTGTTGGCATCCGTCATGTGGAGAGCTTGTCTTAGAGGGCTTTTCTTTGTATGTATAGCTTGCTAGTTTGTTTTCTACATTTCAAAATGTTTAGTTTAGAATAAGTGCATTGCCCACTGATAGAGGTACAATTTTCCAGACTTCCAGAAACTCATCCAATGAACCAACAGTGTCAAAACTTAACTGTGTCCGATACCAAAATGCTTCAGTATTTGTAATTTTTAAAGTCAGATGCTGATGTTCCTGGTCAAAGTTTTTACAGTTACTCTCGAATATCTCCTTTGAATGCTACCTAAGCATGACCGGTATTTTTAAAAGTTGTGAGTAAGCTTTGCAGTTACTGTGAACTCTTGTCTCTTGGAGGAAACTTTTTGTTTAAGAATTGGTATGATTAAACTGAATTCATATATGCAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Centrosome</CellLocal>
      <Ontology_ID>GO:0005813</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Soluble fraction</CellLocal>
      <Ontology_ID>GO:0005625</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Brush border membrane</CellLocal>
      <Ontology_ID>GO:0031526</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane fraction</CellLocal>
      <Ontology_ID>GO:0005624</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>Prkcb</Gene_Name>
    <Gene_Alias>Pkcb; Prkcb1</Gene_Alias>
    <Gene_ID>25023</Gene_ID>
    <Genbank_ACCN>NM_001172305</Genbank_ACCN>
    <Protein_ACCN>NP_001165776</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/25023</Gene_URL>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q8WV44-2</Uniprot_ID>
      <Gene_Name>TRIM41</Gene_Name>
      <EBI_ID>EBI-726015</EBI_ID>
      <PPI_EBI_URL>EBI-397092,EBI-726015</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
  </PPI_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal Structure and Allosteric Activation of Protein Kinase C beta II</PDB_Title>
      <PDB_ID>3PFQ</PDB_ID>
      <Resolution>4.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3PFQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure and Allosteric Activation of Protein Kinase C beta II</PubMed_Title>
      <Author>Leonard, T.A., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2011)144:55-66</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21215369?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>C2 DOMAIN FROM PROTEIN KINASE C (BETA)</PDB_Title>
      <PDB_ID>1A25</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1A25</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the protein kinase Cbeta phospholipid-binding C2 domain complexed with Ca2+.</PubMed_Title>
      <Author>Sutton, R.B., et al.</Author>
      <Journal>Structure(1998)6:1395-1405</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9817842?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.bd.b.c.j.html</SCOP_URL>
    <CATH_Class>Class 2: Mainly Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1a25</CATH_URL>
  </Fold>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.7.11.13</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/7/11/13.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>